CIDRAP newsletters options
State officials said the boy had eaten plum fruit from the neighborhood before his symptoms began.
GPEI said the viruses are closely related each other and a variant that circulated in Egypt in the last half of 2023.
Compared to influenza, COVID-19 patients had longer ICU stays.
Researchers say the findings suggest oversight of C diff patients by infectious disease specialists may result in better outcomes and resource management.
Researchers found a 43% drop in DR-TB case notifications in a South African province after COVID-19 lockdowns were implemented.
Sixteen of 18 people sickened (89%) reported eating meats sliced at deli counters (not packaged meats).
In the entire cohort, 17,704 infants (5.2%) had a major congenital anomaly.
A randomized trial suggests simple interventions for patients with respiratory illness could reduce illness duration, aid antimicrobial stewardship efforts.
Rural children had longer travel times than their urban peers in all demographic subgroups and both vaccine age-groups.
Two wastewater systems show high levels across most of the country.
Colorado's latest layer farm outbreak occurred not far from where culling workers were infected in a similar event.
2-year-olds showed an altered immune response to childhood vaccines in T-cell expression.
A total of 15,700 death certificates listed COVID-19 as a contributing condition, and 3 of 4 recorded a COVID-19 complication or pre-existing condition as the cause.
The highest risk of developing long COVID was seen among patients infected with the original strain of the virus, when no vaccines were available.
Officials are investigating the link to two recent miscarriages and have found clues in earlier blood samples and patient outcomes from the 1980s.
Over 90% of COVID-19 survivors had no neutralizing antibody activity at 10 months, implying that they had lost protection from reinfection.
Lentocilin is the second drug to get FDA clearance for temporary import as rising syphilis infections outstrip treatment supply, including for newborns.
Approved in 2018 for treating pneumonia and skin infections, the drug has shown activity against both gram-positive and gram-negative bacteria, including antibiotic-resistant strains.
A lower risk of severe COVID-19 reinfection and hospitalization was seen with a longer time since dengue infection.
Scientists said until the newer more closely matched vaccine is approved, earlier licensed vaccines might be a useful bridge, if needed.
